Our advice goes beyond the now. We look at the big picture, applying insight and creativity to deliver on strategic objectives.
Whether a privately-owned company or a listed corporate entity, precision and technical expertise is critical to commercial issues and corporate transactions.
Our mergers and acquisitions team helps improve and unlock shareholder value through integrated solutions to divestments, acquisitions and capital raising initiatives.
We draw on our broad experience and industry knowledge to craft innovative structures and solutions for global joint ventures, sales, acquisitions and financing arrangements. We design and execute contracts, transaction documentation and due diligence programs that protect your business and your shareholder interests for the long-term.
Working closely with senior management and boards, we advise on all areas of corporate governance (including directors’ duties and corporate social responsibility) to manage legal, regulatory and commercial risks.
Our funds management lawyers apply in-depth industry knowledge and experience to assist clients across a broad range of areas and identify the best structures and outcomes for entities involved.
We provide tailored, precise, practical advice for tomorrow’s business, not just for today.
To find out more, contact Damien Clarke
Advised on its merger with QT Mutual Bank. The merger between a motoring body and an ADI was the first of its kind globally, providing Queenslanders with a new member-owned force in banking.
Icon Cancer Care Group
Acted for the minority shareholders in the $1.1 billion sale of Icon, Australia’s largest cancer care provider.
Queensland Investment Corporation
Advised on the landmark deal to acquire an 80 percent interest in North Australian Pastoral Company.
Acting for the Fortune 500 company in its continued expansion, including the recent acquisitions of RxWorks and Provet.
Advised on the recent IPOs for Wagners Holding Company Limited, MSL Solutions Limited, Oventus Medical Limited, Over the Wire Holdings Limited, Other Levels Holdings Limited, Anatara Lifesciences Limited, Corporate Travel Management Limited, Seymour Whyte Limited, Ausenco Limited, Genera Biosystems Limited, Invion Limited, Provet Holdings Limited and GBST Holdings Ltd.
Advised Ausenco Limited, Corporate Travel Management Limited, Carbon Energy Limited, Viralytics Limited, Factor Therapeutics Limited, Other Levels Limited, Imugene Limited and Prescient Therapeutics Limited.
Dalian Wanda Group
Advising on the acquisition of Hoyts Cinemas for $850 million.
Whitehaven Coal Limited
Advising on the all scrip merger with Aston Resources Limited, and acquisition of Boardwalk Resources for $5.1 billion.
Murphy Pipe and Civil Group
Acting in the restructure and sale of a 50% interest in gas pipeline contractor Murphy Pipe and Civil Group to UK company J. Murphy & Sons.